UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl

Clinical nephrology, 2012-07, Vol.78 (1), p.24-32

2012

Volltextzugriff (PDF)

Peritonealdialyse

Der Klinikarzt, 2016-08, Vol.45 (7/08), p.364-370

Haag-Weber, Marianne

2016

Volltextzugriff (PDF)

Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: a prospective randomized study

Nephrology, dialysis, transplantation, 2010-07, Vol.25 (7), p.2288-2296

2010

Volltextzugriff (PDF)

Therapeutic equivalence, long-term efficacy and safety of HX575 in the treatment of anemia in chronic renal failure patients receiving hemodialysis

Clinical nephrology, 2009-11, Vol.72 (5), p.380

2009

Volltextzugriff (PDF)

The impact of residual renal function on survival

Nephrology, dialysis, transplantation, 2008-07, Vol.23 (7), p.2123-2126

Haag-Weber, Marianne

2008

Volltextzugriff (PDF)

Personal dialysis capacity (PDCTM) test: a multicentre clinical study

Nephrology, dialysis, transplantation, 2003-04, Vol.18 (4), p.788-796

2003

Volltextzugriff (PDF)

Der geriatrische Patient an der Peritonealdialyse

Der Nephrologe, 2022-02, Vol.17 (2), p.106-111

Haag-Weber, Marianne

2022

Volltextzugriff (PDF)

Uremia and infection: mechanisms of impaired cellular host defense

Nephron (2015), 1993, Vol.63 (2), p.125-131

1993

Volltextzugriff (PDF)

Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients

Nephrology, dialysis, transplantation, 2004-05, Vol.19 (5), p.1224-1230

2004

Volltextzugriff (PDF)

Is absorption of high-dose oral iron sufficient in peritoneal dialysis patients?

Peritoneal dialysis international, 2000-11, Vol.20 (6), p.667-673

2000

Volltextzugriff (PDF)

Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study

Clinical nephrology, 2012-01, Vol.77 (1), p.8-17

2012

Volltextzugriff (PDF)

Protease dependent activation of endothelial cells by peritoneal dialysis effluents

Thrombosis and haemostasis, 1999-10, Vol.82 (4), p.1334-1341

1999

Volltextzugriff (PDF)

Iron status and iron supplementation in peritoneal dialysis patients

Kidney international, 1999-03, Vol.55 (S69), p.S71-S78

1999

Volltextzugriff (PDF)

Influence of new dialysis solutions on outcome in patients treated with peritoneal dialysis

Wiener Klinische Wochenschrift, 2005-12, Vol.117 (S6), p.89-97

Haag-Weber, Marianne

2005

Volltextzugriff (PDF)

Azidose – Alkalose

Medikamente in der Urologie, 2021, p.611-616

2021

Volltextzugriff (PDF)

Treatment Options to Intensify Hemodialysis

Kidney & blood pressure research, 2003-01, Vol.26 (2), p.90-95

Haag-Weber, M.

2003

Volltextzugriff (PDF)

New strategies to prevent Staphylococcus aureus infections in peritoneal dialysis patients

Journal of the American Society of Nephrology, 1998-04, Vol.9 (4), p.669-676

1998

Volltextzugriff (PDF)

New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography

Journal of the American Society of Nephrology, 1998-02, Vol.9 (2), p.290-296

1998

Volltextzugriff (PDF)

Dysfunction of polymorphonuclear leukocytes in uremia

Seminars in nephrology, 1996-05, Vol.16 (3), p.192-201

1996

Volltextzugriff (PDF)

Granulocyte activation during haemodialysis in the absence of complement activation: inhibition by calcium channel blockers

European journal of clinical investigation, 1988-08, Vol.18 (4), p.380-385

1988

Volltextzugriff (PDF)

Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis

Wiener Klinische Wochenschrift, 2005, Vol.117 Suppl 6, p.89

Haag-Weber, Marianne

2005

Volltextzugriff (PDF)

Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions

Journal of the American Society of Nephrology, 1995-12, Vol.6 (6), p.1592-1599

1995

Volltextzugriff (PDF)

Tidal peritoneal dialysis for home-treated patients: Should it be preferred?

American journal of kidney diseases, 1999-02, Vol.33 (2), p.334-343

1999

Volltextzugriff (PDF)

Effect of immunosuppressive drugs on the release of metalloproteinases from human polymorphonuclear leukocytes

Transplant international, 1991-01, Vol.4 (1), p.26-30

1991

Volltextzugriff (PDF)

Ultrasonography of the catheter tunnel in peritoneal dialysis patients: What are the indications?

American journal of kidney diseases, 1999-04, Vol.33 (4), p.722-727

1999

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(24)

Publikationsform

Sprache

Englisch
(31)
Deutsch
(15)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl

Peritonealdialyse

Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: a prospective randomized study

Therapeutic equivalence, long-term efficacy and safety of HX575 in the treatment of anemia in chronic renal failure patients receiving hemodialysis

The impact of residual renal function on survival

Personal dialysis capacity (PDCTM) test: a multicentre clinical study

Der geriatrische Patient an der Peritonealdialyse

Uremia and infection: mechanisms of impaired cellular host defense

Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients

Is absorption of high-dose oral iron sufficient in peritoneal dialysis patients?

Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study

Protease dependent activation of endothelial cells by peritoneal dialysis effluents

Iron status and iron supplementation in peritoneal dialysis patients

Influence of new dialysis solutions on outcome in patients treated with peritoneal dialysis

Azidose – Alkalose

Treatment Options to Intensify Hemodialysis

New strategies to prevent Staphylococcus aureus infections in peritoneal dialysis patients

New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography

Dysfunction of polymorphonuclear leukocytes in uremia

Granulocyte activation during haemodialysis in the absence of complement activation: inhibition by calcium channel blockers

Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis

Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions

Tidal peritoneal dialysis for home-treated patients: Should it be preferred?

Effect of immunosuppressive drugs on the release of metalloproteinases from human polymorphonuclear leukocytes

Ultrasonography of the catheter tunnel in peritoneal dialysis patients: What are the indications?

Suchergebnisse filtern